Blueprint Medicines Statistics

Total Valuation

Realbotix has a market cap or net worth of CAD 80.79 million. The enterprise value is 82.09 million.

Market Cap	80.79M
Enterprise Value	82.09M

Important Dates

The next estimated earnings date is Tuesday, August 19, 2025.

Earnings Date	Aug 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	200.03M
Shares Outstanding	n/a
Shares Change (YoY)	+65.65%
Shares Change (QoQ)	+0.37%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	101.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	23.45
PB Ratio	13.05
P/TBV Ratio	18.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.09
EV / Sales	24.90
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.75, with a Debt / Equity ratio of 0.46.

Current Ratio	0.75
Quick Ratio	0.55
Debt / Equity	0.46
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-20.11

Financial Efficiency

Return on equity (ROE) is -187.76% and return on invested capital (ROIC) is -25.91%.

Return on Equity (ROE)	-187.76%
Return on Assets (ROA)	-24.06%
Return on Invested Capital (ROIC)	-25.91%
Return on Capital Employed (ROCE)	-79.51%
Revenue Per Employee	149,769
Profits Per Employee	-1.15M
Employee Count	23
Asset Turnover	0.21
Inventory Turnover	n/a

Taxes

Income Tax	-573,503
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +215.39% in the last 52 weeks. The beta is 2.88, so Realbotix's price volatility has been higher than the market average.

Beta (5Y)	2.88
52-Week Price Change	+215.39%
50-Day Moving Average	0.39
200-Day Moving Average	0.34
Relative Strength Index (RSI)	56.36
Average Volume (20 Days)	180,192

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.23

Income Statement

In the last 12 months, Realbotix had revenue of CAD 3.44 million and -26.53 million in losses. Loss per share was -0.14.

Revenue	3.44M
Gross Profit	-223,785
Operating Income	-6.35M
Pretax Income	-26.47M
Net Income	-26.53M
EBITDA	n/a
EBIT	-6.35M
Loss Per Share	-0.14

Full Income Statement

Balance Sheet

The company has 1.43 million in cash and 2.85 million in debt, giving a net cash position of -1.43 million.

Cash & Cash Equivalents	1.43M
Total Debt	2.85M
Net Cash	-1.43M
Net Cash Per Share	n/a
Equity (Book Value)	6.19M
Book Value Per Share	0.03
Working Capital	-718,540

Full Balance Sheet

Cash Flow

Operating Cash Flow	-7.63M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	-6.50%
Operating Margin	-184.26%
Pretax Margin	-768.36%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	-184.26%
FCF Margin	n/a

Dividends & Yields

Realbotix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-65.65%
Shareholder Yield	n/a
Earnings Yield	-32.84%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 30, 2021. It was a reverse split with a ratio of 0.0882924.

Last Split Date	Apr 30, 2021
Split Type	Reverse
Split Ratio	0.0882924

Scores

Realbotix has an Altman Z-Score of -2.25 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.25
Piotroski F-Score	2